Erwan Martin
Bioinformatics & Systems Biology
Technical University of Denmark
France
Biography
over 20 years of experience in finance, biotechnology and corporate development. Before joining Cellnovo, Erwan was Chief Financial Officer of Genomic Vision (Euronext: GV), a position he had held since 2009. He was also VP of Corporate Development until 2015, undertaking financing operations such as the Company's initial public offering. He has also worked at Syndex, and co-founded Cytomics Pharmaceuticals, a biotechnology company specialising in the discovery of new medicines.
Research Interest
Bioinformatics & Systems Biology
